290 related articles for article (PubMed ID: 11518075)
21. An in vitro and hydroponic growing system for hypericin, pseudohypericin, and hyperforin production of St. John's wort (Hypericum perforatum CV new stem).
Murch SJ; Rupasinghe HP; Saxena PK
Planta Med; 2002 Dec; 68(12):1108-12. PubMed ID: 12494339
[TBL] [Abstract][Full Text] [Related]
22. The antidepressant mechanism of Hypericum perforatum.
Mennini T; Gobbi M
Life Sci; 2004 Jul; 75(9):1021-7. PubMed ID: 15207650
[TBL] [Abstract][Full Text] [Related]
23. A mechanistic study on altered pharmacokinetics of irinotecan by St. John's wort.
Hu ZP; Yang XX; Chen X; Cao J; Chan E; Duan W; Huang M; Yu XQ; Wen JY; Zhou SF
Curr Drug Metab; 2007 Feb; 8(2):157-71. PubMed ID: 17305494
[TBL] [Abstract][Full Text] [Related]
24. St. John's wort: role of active compounds for its mechanism of action and efficacy.
Butterweck V; Schmidt M
Wien Med Wochenschr; 2007; 157(13-14):356-61. PubMed ID: 17704987
[TBL] [Abstract][Full Text] [Related]
25. Acute effects of LI 160 (extract of Hypericum perforatum, St John's wort) and two of its constituents on neuroendocrine responses in the rat.
Franklin M; Chi JD; Mannel M; Cowen PJ
J Psychopharmacol; 2000; 14(4):360-3. PubMed ID: 11198053
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effect of the antidepressant St. John's wort (hypericum perforatum) on rat bladder contractility in vitro.
Capasso R; Borrelli F; Capasso F; Mascolo N; Izzo AA
Urology; 2004 Jul; 64(1):168-72. PubMed ID: 15245964
[TBL] [Abstract][Full Text] [Related]
27. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of Hypericum perforatum on alcohol intake in rats.
Perfumi M; Panocka I; Ciccocioppo R; Vitali D; Froldi R; Massi M
Alcohol Alcohol; 2001; 36(3):199-206. PubMed ID: 11373255
[TBL] [Abstract][Full Text] [Related]
28. Acute and chronic actions of a dry methanolic extract of Hypericum perforatum and a hyperforin-rich extract on dopaminergic and serotonergic neurones in rat nucleus accumbens.
Rommelspacher H; Siemanowitz B; Mannel M
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S119-26. PubMed ID: 11518060
[TBL] [Abstract][Full Text] [Related]
29. Aqueous ethanolic extract of St. John's wort (Hypericum perforatum L.) induces growth inhibition and apoptosis in human malignant cells in vitro.
Hostanska K; Reichling J; Bommer S; Weber M; Saller R
Pharmazie; 2002 May; 57(5):323-31. PubMed ID: 12061257
[TBL] [Abstract][Full Text] [Related]
30. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377
[TBL] [Abstract][Full Text] [Related]
31. Hypericin and hyperforin production in St. John's wort in vitro culture: influence of saccharose, polyethylene glycol, methyl jasmonate, and Agrobacterium tumefaciens.
Pavlík M; Vacek J; Klejdus B; Kuban V
J Agric Food Chem; 2007 Jul; 55(15):6147-53. PubMed ID: 17608493
[TBL] [Abstract][Full Text] [Related]
32. Variability in PXR-mediated induction of CYP3A4 by commercial preparations and dry extracts of St. John's wort.
Gödtel-Armbrust U; Metzger A; Kroll U; Kelber O; Wojnowski L
Naunyn Schmiedebergs Arch Pharmacol; 2007 Aug; 375(6):377-82. PubMed ID: 17593354
[TBL] [Abstract][Full Text] [Related]
33. Current St John's wort research from mode of action to clinical efficacy.
Müller WE
Pharmacol Res; 2003 Feb; 47(2):101-9. PubMed ID: 12543057
[TBL] [Abstract][Full Text] [Related]
34. Protective effects of St. John's wort extract and its component hyperforin against cytokine-induced cytotoxicity in a pancreatic beta-cell line.
Menegazzi M; Novelli M; Beffy P; D'Aleo V; Tedeschi E; Lupi R; Zoratti E; Marchetti P; Suzuki H; Masiello P
Int J Biochem Cell Biol; 2008; 40(8):1509-21. PubMed ID: 18226577
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous determination of total hypericin and hyperforin in St. John's wort extracts by HPLC with electrochemical detection.
Rückert U; Likussar W; Michelitsch A
Phytochem Anal; 2007; 18(3):204-8. PubMed ID: 17500362
[TBL] [Abstract][Full Text] [Related]
36. Role of hyperforin in the pharmacological activities of St. John's Wort.
Zanoli P
CNS Drug Rev; 2004; 10(3):203-18. PubMed ID: 15492771
[TBL] [Abstract][Full Text] [Related]
37. Hyperforin-containing extracts of St John's wort fail to alter gene transcription in brain areas involved in HPA axis control in a long-term treatment regimen in rats.
Butterweck V; Winterhoff H; Herkenham M
Neuropsychopharmacology; 2003 Dec; 28(12):2160-8. PubMed ID: 12865894
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of action of St John's wort in depression : what is known?
Butterweck V
CNS Drugs; 2003; 17(8):539-62. PubMed ID: 12775192
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of hepatocellular toxicity associated with the components of St. John's Wort extract hypericin and hyperforin in HepG2 and HepaRG cells.
Abegg VF; Panajatovic MV; Mancuso RV; Allard JA; Duthaler U; Odermatt A; Krähenbühl S; Bouitbir J
Toxicol Lett; 2024 Mar; 393():1-13. PubMed ID: 38219807
[TBL] [Abstract][Full Text] [Related]
40. Antidepressant activity of hypericum perforatum and hyperforin: the neglected possibility.
Chatterjee SS; Nöldner M; Koch E; Erdelmeier C
Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():7-15. PubMed ID: 9684942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
